Mochida Pharmaceutical Co.,Ltd. [4534.T]
TOKYO, Apr 06 (Pulse News Wire) – Mochida Pharmaceutical CO.,LTD. (4534.T) announced today that the price for its ordinary share sale was set at ¥3,331 per share through a resolution made during the board meeting held on March 30, 2026.
The total value of the shares offered will amount to ¥3.843 billion. The subscription period for the sale will run from April 07, 2026 to April 08, 2026, with delivery scheduled for April 13, 2026. Additionally, the company plans to sell an additional 173,000 shares via an over-allotment option, priced at ¥3,331 per share, with subscriptions taking place from April 7 to April 8, 2026, and deliveries due on April 13, 2026.
The discount rate applied for determining the selling price was calculated based on the benchmark day of April 6, 2026, at ¥3,435. The green shoe option exercise period will extend from April 13 to April 23, 2026, while Syndicate Cover Torihiki Kikan will remain open from April 09, 2026 to April 23, 2026. Investors are advised to review the prospectus and any amendments prepared by the company prior to making investment decisions.
The securities mentioned herein have not been and will not be registered under the United States Securities Act of 1,933 and cannot be publicly offered or solicited without such registration or exemption therefrom.
🟢 Confidence: High AI-translated content.